Former Trump Advisor: "This Could Destroy Families"

A huge change is coming to America, and it scares the life out of former Trump advisor Brad Thomas. He calls it "America's next big economic crisis" and warns it will forever reshape our country, potentially destroying lives and ripping families apart. And according to him, even President Trump can't stop it.

Popular

Stock Of The Day: Is Pfizer Set Up To Rally?

Shares of Pfizer (PFE) may be about to reverse and head higher. They are both oversold and at a support level.

Cannabis Could Save $29 Billion Per Year In U.S. Healthcare Costs, Says CEO

Leafwell CEO Emily Fisher reveals medical cannabis could save U.S. healthcare $29 billion annually, citing new research.

Crypto Stocks Surge Amid Market Boom - Ad

Crypto stocks are on fire as Bitcoin hits all-time highs. One under-the-radar company is leading the charge, managing $2.1 billion in client assets and seeing record trading volumes. With crypto adoption skyrocketing, this could be a game-changing opportunity.

Will Mark Cuban Join Rivals Elon Musk, Vivek Ramaswamy's DOGE? 'Shark Tank' Host Says 'Both Know How To Reach Me'

Mark Cuban has expressed willingness to collaborate with Elon Musk and Vivek Ramaswamy's Department of Government Efficiency (DOGE) by offering his Cost Plus Drug Company to help cut federal healthcare costs through its transparent and affordable pricing model.

Eli Lilly's Investigational Drug Cuts Sticky Cholesterol Levels By Almost 86%

Eli Lilly's muvalaplin Phase 2 trial showed significant Lp(a) reduction, meeting primary and secondary endpoints with favorable safety data.

As Dangerous As Covid-19? - Ad

Experts from Harvard, MIT, and Stanford have warned THIS could be as dangerous as the COVID-19 pandemic. But it isn't a health pandemic. It's a financial "disease" that has already infected the US economy. Soon, the symptoms will show, potentially destroying your retirement dreams forever. Today, a former Trump advisor is stepping forward to reveal the truth.

Better drugs through AI? Insitro CEO on what machine learning can teach Big Pharma

WASHINGTON (AP) — Artificial intelligence is changing the way companies do business — helping programmers write code and fielding customer service calls with chatbots.

As temperatures turn frigid, Minnesotans turn to saunas for warmth and community

EAGAN, Minn. (AP) — Ed Kranz set up his mobile sauna next to a frozen beach at Lebanon Hills Regional Park in Eagan, Minnesota, on a bone-chilling Sunday morning during a weekend cold snap.

Firm Issues Rare "All In" Buy Alert on $6 Gold Stock - Ad

The bull market in gold is just getting started...In fact, many top analysts are predicting gold could go much, much higher. But you should NOT just rush out and buy gold bars or coins. We've found a gold play that's much better...And priced at $6 today, this stock has tremendous upside potential as the price of gold continues to rise.

Massachusetts lawmakers push for an effort to ban all tobacco sales over time

BOSTON (AP) — A handful of Massachusetts lawmakers are hoping to persuade their colleagues to support a proposal that would make the state the first to adopt a ban meant to eliminate the use of tobacco products over time.

Regulators cracked down on sweet vapes after use by kids spiked. Now the Supreme Court is wading in.

WASHINGTON (AP) — Vaping is coming before the Supreme Court next week as federal regulators ask the high court to uphold its block on sweet, flavored products following a spike in youth e-cigarette use.

How Musk & Trump Could Launch These Stocks Higher - Ad

Tesla (TSLA) stock has surged. But the real opportunity? Musk's AI venture, xAI. With Trump's presidency, xAI could soon lead the AI race, backed by strong government connections and fewer regulatory barriers. This powerhouse collaboration could fuel massive growth in the AI sector, and xAI may become Elon's biggest company yet.

Why Is Exact Sciences Stock Trading Higher On Tuesday? (CORRECTED)

Centers for Medicare & Medicaid Services finalizes 2025 pricing for Exact Sciences' Cologuard Plus, raising Medicare reimbursement by 16% and boosting growth projections for next year.

Bird Flu Found In Raw Milk Leads To Recall In California

Bird flu has been detected in a batch of raw milk sold in California and a voluntary recall of the milk has been issued at the request of the state's department of public health.

This $2 Stock Outshines Historic Gold Rally! - Ad

Gold has soared 25% in the last 6 months, but this young company has more than doubled that return. With a price target nearly double its current value, it's caught the eye of 40+ investment banks and funds. Discover the name of this standout company today and see why it's a potential gold mine for investors.

At least 15 people are sick in Minnesota from ground beef tied to E. coli recall

At least 15 people in Minnesota have been sickened by tied to a national recall of more than 167,000 pounds of potentially tainted ground beef, federal health officials said.

Boar's Head listeria outbreak is over with 10 dead and dozens sickened by tainted deli meat

A deadly outbreak of listeria food poisoning tied to a of popular Boar's Head deli meats is over, federal health officials said Thursday.

Why Is This Bull Run Scaring JP Morgan, Goldman Sachs, and Warren Buffett? - Ad

Billionaires Warren Buffett, Stanley Druckenmiller, and David Tepper have all sold off massive U.S. stock positions. Billionaire Ray Dalio, who runs one of the world's most successful hedge funds, says, "Things are going to get worse for our economy." What are these billionaires so worried about?

Which health insurance plan may be right for you?

Everyone likes a good deal, and health insurance bargains abound . But buyers should look beyond price when searching for a plan.

Trump Picks Dr. Oz As Centers For Medicare And Medicaid Services Administrator

President-elect Donald Trump on Tuesday said that he will nominate celebrity physician Dr. Mehmet Oz to lead the Centers for Medicare & Medicaid Services (CMS).

Forget Nvidia, Apple, Tesla, and Google - Ad

Market Wizard Larry Benedict: "Forget 99% of stocks: It's possible to make all the money you need for a happy retirement with just this one."

Tackling estate planning in 7 basic steps

Estate planning is one of those tasks that makes almost any other job look appealing, no matter how lowly.

Moderna Remains Confident Despite Political Concerns Over Vaccine Safety and HHS Nomination

Moderna plans to prioritize new product approvals and oncology investments, as political concerns over Robert F. Kennedy Jr.'s HHS nomination weigh on vaccine stocks.

Tech Funds Are Hemorrhaging Cash: Sell This Stock Now - Ad

U.S. technology funds are HEMORRHAGING cash. It's the biggest selloff since the 2022 bear market. A 50-year Wall Street veteran just explained everything you need to know. For now, he's pounding the table on the No. 1 tech stock to BUY before 2024 comes to an end... And the No.1 tech stock Wall Street says to sell NOW.

Goldman Sachs Economist: Weight-Loss Drugs Could Be Key To US Economic Growth

A Goldman Sachs economist has suggested that the US economy could experience accelerated growth with increased use of GLP-1 weight-loss drugs like Ozempic.

The Trump Surge Sectors! - Ad

According to millionaire-trader Jeff Clark, President Trump's bold agenda is poised to unleash a historic trading opportunity. Already, Trump's sweeping victory has launched the DOW, NASDAQ, and BITCOIN to record highs. And now, Jeff has identified a group of niche-sectors poised to surge as President Trump fuels America's economic renaissance.

Soligenix Kickstarts Dusquetide Mid-Stage Study For Patients With Inflamed Blood Vessels

Soligenix starts Phase 2 trial of SGX945 for Behçet's Disease, aiming to enroll 25 patients and report results by mid-2025. Trial includes efficacy assessments.

Will President Trump's "MAGA-Secret" Ignite Stocks in 2025? - Ad

It's responsible for the biggest wins in stock market history. It predicted Trump's sweeping victory. And now, this pattern says a handful of niche-sectors are poised to surge. Of course, most people don't know how this pattern works. But millionaire-trader Jeff Clark has used it for 40 years to generate over 1,000 winning trade recommendations.

FDA Commissioner Califf Candid on Trump's Impact: 'We Just Don't Know What's Going to Happen'

FDA Chief Robert Califf reflects on potential changes as Trump's re-election looms, expressing disappointment and highlighting uncertainty within the agency.

Kraft Heinz stops serving school-designed Lunchables because of low demand

Food and beverage manufacturer said Tuesday that it no longer is serving the Lunchables meals it created for U.S. schools.

What Does Trump's Presidency Mean for Elon Musk's AI Venture? - Ad

As new allies, Trump and Musk could reshape America's AI future. Elon Musk's AI startup, xAI, might gain the edge it needs to dominate the industry. A shift in government support, fewer barriers, and a potential "backdoor" into the AI race are just the beginning. Is xAI set to become Elon's most powerful venture yet?

23andMe cuts 40% of its workforce and discontinues therapeutics division

NEW YORK (AP) — is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the struggling genetic testing company attempts to slash costs.

Relaxation Emerges As Strongest Predictor Of Psychedelic Therapy Benefits, Study

Study reveals relaxation, not mystical experiences, as the main factor in the success of psychedelic therapy for treatment-resistant depression.

The Same "Magic Pattern" That Predicted Trump's Win Now Predicts These Niche-Trades Will Surge! - Ad

It's responsible for the biggest wins in stock market history. It predicted Trump's sweeping victory. And now, this pattern says a handful of niche-sectors are poised to surge. Of course, most people don't know how this pattern works. But millionaire-trader Jeff Clark has used it for 40 years to generate over 1,000 winning trade recommendations.

Moderna's Q3 Earnings Beat Overshadowed By Vaccine Demand Slowdown And Market Share Concerns, Analysts Warn

Moderna's stock faces a decline as analysts lower the price target to $90, citing weaker vaccine demand and concerns over upcoming COVID and RSV sales.

Recommended

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service